SEATTLE, May 25, 2021, (MEDGADGET) — Rest of the World Factor VIII Deficiency Treatment Market Analysis
Drivers
Over the forecast period, new product releases by major companies in the factor VIII deficiency treatment are expected to fuel growth of the rest of the world factor viii deficiency treatment market during the forecast period. The European Commission granted Novo Nordisk marketing authorization for Esperoct in Europe in June 2019. Turoctocog alfa pegol, N8-GP, is a brand name for turoctocog alfa pegol, a drug used to treat hemophilia A in children and adults. Furthermore, Roche Products India Pvt. Ltd. unveiled emicizumab, a hemophilia A drug marketed in India as Hemlibra, in April 2019. Via Factor VIII inhibitors, it is suggested as a prophylactic therapy for reducing the incidence of bleeding episodes in patients with hemophilia A.
Request A Sample Copy – Rest of the World Factor VIII Deficiency Treatment Market Report Click here: https://www.coherentmarketinsights.com/insight/request-pdf/3257
Moreover, rising government efforts to raise public concern over hemophilia care are projected to drive growth of the rest of the world factor viii deficiency treatment market over the forecast period. To promote the successful control of hemophilia in Australia, the NBA (National Bleeding Authority) offers grants to AHCDO (Australian Hemophilia Center Directors’ Organization) for care and management of hemophilia A.
Over the forecast period, the rest of the world factor VIII deficiency treatment market is estimated to grow at a CAGR of 4.7 percent (2019-2027).
The rest of the world factor VIII deficiency treatment market is expected to rise due to an increase in the number of cases of bleeding disorders.
Due to an increase in cases of hemophilia or bleeding disorders, the rest of the world factor VIII deficiency treatment market is forecast to expand significantly. As per the Australian Bleeding Disorders Registry 2016 numbers, there were approximately 4,941 patients diagnosed with common inherited bleeding disorders in Australia in 2015, with 2,301 patients diagnosed with hemophilia A and 548 patients diagnosed with hemophilia B. Over the forecast period, the rising prevalence of hemophilia in Australia is projected to boost demand for factor VIII deficiency therapy. Furthermore, over the forecast period, rising demand for effective therapeutics for the treatment of factor VIII deficiency from developing economies such as India is expected to fuel market growth. As per 2017 figures from the World Federation of Hemophilia, about 18,353 people in India were diagnosed with hemophilia in 2016.
The market is expected to expand due to rising healthcare spending and reimbursement policies in various countries or regions.
Due to the per capita healthcare spending in Latin America, which is expected to fuel demand growth in the region over the forecast period, Latin America is expected to maintain a leading position in the rest of the world factor VIII deficiency treatment market. As per World Bank figures, healthcare spending per capita rose dramatically across Latin America over a six-year period (2008-2014), with increases of 31% in Brazil, 54% in Chile, and 58 percent in Columbia.
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/3257
Furthermore, due to increasing favorable reimbursement policies for hemophilia care in economies such as China, Asia Pacific is projected to be the second largest dominant area in the rest of the world factor VIII deficiency treatment market. As per a 2012 survey by the Chinese Ministry of Health, outpatient hemophilia care is provided by health insurance policies in more than 80% of Chinese towns, with coverage caps and patient co-pay thresholds above 50%. Furthermore, annual reimbursement is normally less than US$ 16,000 a year.
Key Players
Key companies contributing in the rest of the world factor VIII deficiency treatment market are CSL Behring, Bayer AG, Biogen, Inc., Kedrion, Baxter International, Inc., Novo Nordisk A/S, Pfizer, Inc., F. Hoffmann-La Roche AG, and Ferring B.V.
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/rest-of-the-world-factor-viii-deficiency-treatment-market-2626
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- New Therapy Developments
- Epidemiology
- Regulatory Scenario
- Regulatory Guidelines
- Reimbursement Scenario
- PEST Analysis
- Product Launch
- PEST Analysis
- Market Dynamics
- Rest of the World Factor VIII Deficiency Treatment Market, By Product Type, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Plasma Derived Coagulation Factor Concentrates
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Million and Thousand Units)
- Recombinant Coagulation Factor Concentrates
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Million and Thousand Units)
- Biologic (Hemlibra)
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Million and Thousand Units)
- Desmopressin
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Million and Thousand Units)
- Introduction
- Rest of the World Factor VIII Deficiency Treatment Market, By Distribution Channel, 2016 – 2027, (US$ Million)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Rest of the World Factor VIII Deficiency Treatment Market, By Region, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2027
- Latin America
- Market Size and Forecast, By Product Type, 2016 – 2027, ((US$ Million) and Volume (Thousand Units)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size (US$ Million), Volume (Thousand Units) and Forecast, and Y-o-Y Growth, By Country, 2016–2027)
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of Latin America
- Asia Pacific
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million) and Volume (Thousand Units)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size (US$ Million), Volume (Thousand Units) and Forecast, and Y-o-Y Growth, By Country, 2016–2027)
- China
- India
- Japan
- ASEAN
- Indonesia
- Malaysia
- Philippines
- Singapore
- Thailand
- Rest of ASEAN Countries
- Australia
- South Korea
- Pakistan
- Rest of Asia Pacific
- Middle East & Russia
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- GCC
- Saudi Arabia
- United Arab Emirates
- Israel
- Russia
- Turkey
- Rest of Middle East
- GCC
- Africa
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million) and Volume (Thousand Units)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size (US$ Million), Volume (Thousand Units) and Forecast, and Y-o-Y Growth, By Country/Region, 2016–2027)
- North Africa
- Algeria
- Egypt
- Tunisia
- Central Africa
- South Africa
- North Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Analyst Views
- Section
- References
- Research Methodology
- About Us and Sales Contact
Other Related Reports:
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837